Announcements Trials

Browse Landscape

Phase

Phase 2 8 Phase 1 3 Phase 1/2 2 Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 2 Breast Neoplasms 2 Multiple Myeloma 1 Lymphoma, T-Cell 1 Lymphoma 1 Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 25 Rituximab 18 fludarabine phosphate 15 Radiotherapy 13 Methotrexate 13 Peripheral Blood Stem Cell Transplantation 12 Filgrastim 12 Cytarabine 12 Vincristine 11 Melphalan 10 Cyclosporine 10 Busulfan 10 Antilymphocyte Serum 10 Exercise 9 Doxorubicin 9 Prednisone 7 Mycophenolic Acid 7 Magnetic Resonance Spectroscopy 7 Etoposide 7 Early Intervention, Educational 7 Whole-Body Irradiation 6 Surveys and Questionnaires 6 Prednisolone 6 Palliative Care 6 Methods 6 Leucovorin 6 Educational Status 6 Blood Specimen Collection 6 Dexamethasone 5 pegylated granulocyte colony-stimulating factor 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma × liposomal doxorubicin × Clear all

NCT00141648 2009-10-01

Chemotherapy and Radiotherapy for Osteolymphoma

Trans Tasman Radiation Oncology Group

Phase NA Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡